- Home
- KMDA vs ANGO Comparison
KMDA vs ANGO Comparison
Compare KMDA & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- ANGO
- Stock Information
- Founded
- KMDA 1990
- ANGO 1988
- Country
- KMDA Israel
- ANGO United States
- Employees
- KMDA N/A
- ANGO N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- ANGO Medical/Dental Instruments
- Sector
- KMDA Health Care
- ANGO Health Care
- Exchange
- KMDA Nasdaq
- ANGO Nasdaq
- Market Cap
- KMDA 443.4M
- ANGO 400.8M
- IPO Year
- KMDA N/A
- ANGO 2004
- Fundamental
- Price
- KMDA $7.72
- ANGO $9.22
- Analyst Decision
- KMDA Strong Buy
- ANGO Strong Buy
- Analyst Count
- KMDA 2
- ANGO 3
- Target Price
- KMDA $13.00
- ANGO $19.00
- AVG Volume (30 Days)
- KMDA 55.4K
- ANGO 880.7K
- Earning Date
- KMDA 08-13-2025
- ANGO 07-15-2025
- Dividend Yield
- KMDA 2.59%
- ANGO N/A
- EPS Growth
- KMDA 31.21
- ANGO N/A
- EPS
- KMDA 0.28
- ANGO N/A
- Revenue
- KMDA $167,235,000.00
- ANGO $292,498,000.00
- Revenue This Year
- KMDA $14.51
- ANGO $6.31
- Revenue Next Year
- KMDA $9.31
- ANGO $7.35
- P/E Ratio
- KMDA $28.31
- ANGO N/A
- Revenue Growth
- KMDA 11.83
- ANGO N/A
- 52 Week Low
- KMDA $5.08
- ANGO $5.83
- 52 Week High
- KMDA $9.16
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- KMDA 53.97
- ANGO 46.66
- Support Level
- KMDA $7.64
- ANGO $8.38
- Resistance Level
- KMDA $7.91
- ANGO $9.37
- Average True Range (ATR)
- KMDA 0.18
- ANGO 0.55
- MACD
- KMDA -0.02
- ANGO 0.03
- Stochastic Oscillator
- KMDA 50.00
- ANGO 34.71
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.